Roslin scientists and colleagues at the Burnham Institute for Medical Research in La Jolla, California, are studying how enzymes control production of calcium phosphate in the skeleton. Up to 10 percent of the total bone mass is renewed by calcification every year - but elsewhere in the body calcification is a problem that can lead to kidney stones, hardened arteries or osteoarthritis. The research will help to understand why calcification normally only occurs in bone, and how this is controlled.
The identification of the role of the enzyme PHOSPHO1 in bone calcification at Roslin, a sponsored institute of the Biotechnology and Biological Sciences Research Council (BBSRC), has directly led to the £1M from the US National Institute of Health to take the research forward.
PHOSPHO1 plays a key role in healthy bone development by producing inorganic phosphate, as Dr Colin Farquharson from the Roslin Institute explained: "This is one of the first steps in a process where mineral crystals of calcium phosphate are produced and laid down in precise amounts within the bone's scaffolding."
The joint research project will be investigating how PHOSPHO1 interacts with other enzymes to control skeleton calcification and limit calcium production in other parts of the body.
Dr Farquharson explained: "By blocking PHOSPHO1 production, we can reduce initial mineralisation, or calcification, by up to 70 percent. But there must be other enzymes and pathways involved, to account for the remaining level of mineralisation."
Professor Julia Goodfellow, Chief Executive of BBSRC, said: "This US funded project shows the research at Roslin Institute is recognised internationally. This research will provide fundamental insights into the mechanisms of normal bone mineralisation, which could lead to therapeutic strategies for disorders such as osteoarthritis, osteoporosis and hardened arteries."
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy